Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The NHS Commissioning Board (operating under the name of NHS England)
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: michelle.clarke6@nhs.net
NUTS: UK
Internet address(es)
Main address: https://nhsengland.bravosolution.co.uk
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS Framework Agreement for Branded Medicines – National Interim
Reference number: CM/PHR/19/5584
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHS Framework Agreement for Branded Medicines – National Interim
Offer reference number: CM/PHR/19/5584
Period of framework agreement: 1 May 2020 to 30 April 2021 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
163 500 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKC
UKD
UKE
UKF
UKG
UKH
UKI
UKJ
UKK
Main site or place of performance:
Please refer to document 3 schedule 8 in the ITO documents for the full list of purchasing points.
II.2.4) Description of the procurement
CM/PHR/19/5584 — 1 May 2020 to 30 April 2021 — NHS Framework Agreement for Branded Medicines – National Interim — with an option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
II.2.5) Award criteria
Quality criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: as above
Cost criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: as above
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2020/S 005-006223
IV.2.9) Information about termination of call for competition in the form of a prior information notice
The contracting authority will not award any further contracts based on the above prior information notice
Section V: Award of contract
Contract No: CM/PHR/19/5584
Title: NHS Framework Agreement for Branded Medicines – National Interim — with an Option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/05/2020
V.2.2) Information about tenders
Number of tenders received: 11
Number of tenders received from SMEs: 5
Number of tenders received by electronic means: 11
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Aventis Pharma Ltd Trading as Sanofi
410 Thames Valley Park Drive
Reading, Berkshire
RG6 1PT
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Cenote Pharma Ltd
24-32 Griffin Court
Newbury, Berkshire
RG14 1JX
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.3) Name and address of the contractor
ELI Lilly and Company Ltd
Lilly House Priestley Road
Basingstoke, Hants
RG24 9NL
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Gmp-Orphan Ltd
SB Business Centre Triq Dun Karm, Birkirkara Bypass, Malta
Birkirkara
BKR 9038
MT
NUTS: MT
The contractor is an SME:
Yes
V.2.3) Name and address of the contractor
Janssen Cilag Ltd
50-100 Holmers Farm Way
HighWycombe
HP12 4EG
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Sandoz Ltd
Park View Riverside Way Watchmoor Park
Camberley, Surrey
GU15 3YL
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.3) Name and address of the contractor
Thornton and Ross Ltd
Manchester Road Linthwaite
Huddersfield
HD7 5QH
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Tillomed Laboratories Ltd
220 Butterfield Great Marlings
Luton
LU2 8DL
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Univar Solutions B.V.
Schouwburgplein 30 - 34 The Netherlands
Rotterdam
3012 CL
NL
NUTS: NL
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 163 500 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The suppliers selected to participate in the framework agreement are:
Aventis Pharma Ltd
T/A SANOFI
Cenote Pharma
Eli Lilly and Co. Ltd
GMP Orphan
Janssen-Cilag Ltd
Sandoz Ltd
Thornton and Ross
Tillomed Laboraroties Ltd
Univar
VI.4) Procedures for review
VI.4.1) Review body
The Royal Courts of Justice
London or any of the district registry of the High Court
UK
VI.5) Date of dispatch of this notice
22/05/2020